Find a Doctor

Ming-jui L. Hung

Chang Gung University

Bio


Ming-jui Hung is in Keelung, Taiwan. They have been an author on 81 peer reviewed articles in the past 15 years.

Contact

Keelung, TNQ, TW

Latest Research


Latest Advance
Study
  • Condition: Patients with Type 2 Diabetes (T2D) with Non-Alcoholic Fatty Liver Diseases (NAFLDs)
  • Journal: BMJ open diabetes research & care
  • Treatment Used: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors
  • Number of Patients: 0
  • Published —
This review of the literature examined the effects of sodium glucose co-transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes (T2D) with non-alcoholic fatty liver diseases (NAFLDs).
Latest Advance
Study
  • Condition: Type 2 Diabetes
  • Journal: Cardiovascular diabetology
  • Treatment Used: Sodium Glucose Cotransporter 2 Inhibitors (SGLT2)
  • Number of Patients: 10140
  • Published —
This study compared the glycemic (blood sugar) and pleiotropic effects in patients with type 2 diabetes initiating sodium glucose cotransporter 2 (SGLT2) inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors.
Latest Advance
Study
  • Condition: First Myocardial Infarction in Patients with Atrial Fibrillation (AF)
  • Journal: PloS one
  • Treatment Used: Drug-Eluting vs. Bare-Metal Stents (BMS)
  • Number of Patients: 1221
  • Published —
This study investigated the use of a bare-metal stent (BMS) or a drug-eluting stent (DES) and associated outcomes in patients with pre-existing atrial fibrillation (heart quivering; AF) and first acute myocardial infarction (heart attack; AMI) undergoing percutaneous coronary intervention.
Latest Advance
Study
  • Condition: Aminotransferase (ALT) levels in people with type 2 diabetes
  • Journal: Diabetes, obesity & metabolism
  • Treatment Used: Sodium-glucose co-transporter-2 inhibitors
  • Number of Patients: 1300000
  • Published —
The study researched the effects of sodium-glucose co-transporter-2 inhibitors on aminotransferase (ALT) levels in people with type 2 diabetes.
Latest Advance
Study
  • Condition: Type 2 Diabetes Mellitus
  • Journal: Journal of diabetes investigation
  • Treatment Used: Vildagliptin
  • Number of Patients: 1250
  • Published —
This study analyzed cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Keelung, TNQ, TW

Insurance

Contact them to find out if they accept your insurance plan.